Trial Profile
A Phase III, Multicentre, Randomised, Placebo-Controlled, Double Blind Study of the Incidence of Recurring Pulmonary Exacerbations in Cystic Fibrosis Patients using Two Different Doses of Inhaled Nacystelyn
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 13 Aug 2020
Price :
$35
*
At a glance
- Drugs Acetylcysteine lysinate (Primary)
- Indications Cystic fibrosis
- Focus Therapeutic Use
- Sponsors Laboratoires SMB
- 26 Nov 2015 New trial record